Ovarian cancer (OCa) is a common malignancy in women, and the role of cuproptosis and its related genes in OCa is unclear. Using the GSE14407 dataset, we analyzed the expression and correlation of cuproptosis-related genes (CRGs) between tumor and normal groups. From the TCGA-OV dataset, we identified 20 cuproptosis-related long non-coding RNAs (CuLncs) associated with patient survival through univariate Cox analysis. OCa patients were divided into early-stage and late-stage groups to analyze CuLncs expression. Cluster analysis classified patients into two clusters, with Cluster1 having a poorer prognosis. Significant differences in “Lymphatic Invasion” and “Cancer status” were observed between clusters. Seven CRGs showed significant expression differences, validated using the human protein atlas (HPA) databases. Immune analysis revealed a higher ImmuneScore in Cluster1. GSEA identified associated signaling pathways. LASSO regression included 11 CuLncs to construct and validate a survival prediction model, classifying patients into high-risk and low-risk groups. Correlations between riskScore, Cluster phenotype, ImmuneScore, and immune cell infiltration were explored. Cell experiments showed that knocking down AC023644.1 decreases OCa cell viability. In conclusion, we constructed an accurate prognostic model for OCa based on 11 CuLncs, providing a basis for prognosis assessment and potential immunotherapy targets.
Background: Pelvic organ prolapse (POP) is a common pelvic floor disorder in middle‐aged and elderly women. Its pathophysiology is complex, involving weakened pelvic floor muscles and connective tissues. There is a need to explore its underlying pathogenesis and develop effective treatments. Methods: We integrated single‐cell sequencing (scRNA‐seq) data analysis with Mendelian randomization (MR) analysis. scRNA‐seq data of vaginal mucosal tissue were obtained from individuals with and without pelvic organ prolapse (POP); we then performed dimensionality reduction and cell subset identification. MR was conducted using GWAS summary statistics and eQTL data, following STROBE‐MR guidelines. We also performed protein‐protein interaction analysis, functional enrichment analysis, drug prediction, and molecular docking. Results: We identified RBP7 as a POP risk factor and SCGB3A1 as a protective factor. RBP7 high expression increased POP risk (IVW, OR 1.262, 95% CI 1.093–1.459, p = 0.002), whereas SCGB3A1 high expression decreased it (IVW, OR 0.907, 95% CI 0.844–0.975, p = 0.008). We found associated key genes and their biological processes and signaling pathways. We also predicted potential drugs and their binding affinities. Conclusion: The study highlights the significance of fibroblast gene expression changes in collagen metabolism for POP. It identified risk and protective genes and explored potential drugs. Future research should verify SCGB3A1 functions in fibroblasts, conduct preclinical drug trials, and clarify POP molecular mechanisms.